Marcin Protasiewicz

ORCID: 0000-0003-0253-0585
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Valve Diseases and Treatments
  • Coronary Interventions and Diagnostics
  • COVID-19 Clinical Research Studies
  • Cardiac Imaging and Diagnostics
  • Renal and Vascular Pathologies
  • Infective Endocarditis Diagnosis and Management
  • COVID-19 and healthcare impacts
  • Aortic Disease and Treatment Approaches
  • Aortic aneurysm repair treatments
  • Cardiovascular Function and Risk Factors
  • Blood Pressure and Hypertension Studies
  • Cerebrovascular and Carotid Artery Diseases
  • Venous Thromboembolism Diagnosis and Management
  • Long-Term Effects of COVID-19
  • Atrial Fibrillation Management and Outcomes
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Laser Applications in Dentistry and Medicine
  • Vascular Procedures and Complications
  • Acute Myocardial Infarction Research
  • Cardiac Arrhythmias and Treatments
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiovascular Issues in Pregnancy
  • Cardiovascular Health and Disease Prevention
  • Neurological Complications and Syndromes
  • Lipoproteins and Cardiovascular Health

Wroclaw Medical University
2016-2025

Cedars-Sinai Medical Center
2022-2024

Medical University of Warsaw
2016-2024

Polon (Poland)
2023

University of Wrocław
2003-2021

Azienda Ospedaliera Citta' della Salute e della Scienza di Torino
2019

Wroclaw Research Centre EIT+ (Poland)
2014-2017

Jagiellonian University
2016

Health Center
2016

Central Clinical Hospital
2016

Andreas Baumbach Niels van Royen Ignacio J. Amat‐Santos Martin Hudec Matjaž Bunc and 95 more Alexander Ijsselmuiden Peep Laanmets Daniel Unić Béla Merkely Renicus S. Hermanides Vlasis Ninios Marcin Protasiewicz Benno J. Rensing Pedro Martín Fausto Feres Manuel Almeida Éric Van Belle Axel Linke Alfonso Ielasi Matteo Montorfano Mark Webster Konstantinos Toutouzas Emmanuel Teíger Francesco Bedogni Michiel Voskuil Manuel Pan Oskar Angerås Won‐Keun Kim Jürgen Rothe Ivica Kristić Vicente Peral Scot Garg Hesham Elzomor Akihiro Tobe Marie‐Claude Morice Yoshinobu Onuma Osama Soliman Patrick W. Serruys Dimytri Siqueira Ibraim Pinto Alberto Cervone Jorge Eduardo Assef Andréa Andrade Vilela A. Paladino Auristela Ramos Mariana T. Rezende Samira Kaissar Ghorayeb Tacianne Rolemberg Braga Silva Savica Gjorgjievska Irzal Hadžibegović Ivana Jurin Tomislav Šipić Nikola Pavlović Igor Rudež Šime Manola Romain Gallet Madjid Boukantar Eroan Nicolas Pierre Valdimir ENNEZAT Jean Marie Urien Flavien Vincent Cédric Delhaye Tom Denimal Alessandro Cosenza Thibault Pamart Sina Porouchani François Pontana David Montaigne Vincent Balmette Mohamed Yahya Bechiri Elisabeth Chen Dany Janah Matthias Renker Dirk Westermann Christian Valina Mirosław Ferenc Nikolaus Löffelhardt Faridun Rahimi Philipp Breitbart Kilian Franke Martin Czerny Nawras Diab Peter Sick Medea Adeishvili Norman Mangner Stephan Haußig Krunuslav Sveric Lisa Crusius Marie Roehlig Leonidas Koliastasis Maria Drakopoulou Odysseas Katsaros Nikolaos Ktenopoulos Andreas Ioanniadis Sotirios Evangelou Ilias Ninios Levente Molnár Roland Papp Ferencz Arnold-Béla Orsolya Kiss

10.1016/s0140-6736(24)00821-3 article EN The Lancet 2024-05-22

In previous studies on the effect of renal stenting arterial hypertension, patients were selected mainly basis angiographic parameters artery stenosis. The aim present study was to evaluate whether translesional pressure gradients could identify with stenosis who might benefit from stenting.A total 53 consecutive hypertensive unilateral RAS scheduled for intervention recruited. Transstenotic measured at baseline and during maximal hyperemia, before stenting. Twenty-four-hour ambulatory blood...

10.1161/circinterventions.110.957704 article EN Circulation Cardiovascular Interventions 2010-11-16

Patients with heart failure (HF) are at high risk of unfavorable courses COVID-19. The aim this study was to evaluate characteristics and outcomes COVID-19 patients HF.Data hospitalized in a tertiary hospital Poland between March 2020 May 2021 laboratory-confirmed were analyzed. population divided into HF group (patients history HF) non-HF group.Out 2184 (65 ± 13 years old, 50% male), 12% had HF. from the older, more often males, comorbidities, dyspnea, pulmonary peripheral congestion,...

10.3390/jcm11010241 article EN Journal of Clinical Medicine 2022-01-03

Thanks to advances in interventional cardiology technologies, catheter-directed treatment has become recently a viable therapeutic option the of patients with acute pulmonary embolism at high risk early mortality. Current transcatheter techniques allow for local fibrinolysis or embolectomy minimal complications. Therefore, these procedures can be considered high-risk as an alternative surgical when systemic thrombolysis is contraindicated ineffective. They are also intermediate-high-risk who...

10.33963/kp.a2023.0075 article EN Kardiologia Polska 2023-04-28

Thanks to advances in interventional cardiology technologies, catheter-directed treatment has become recently a viable therapeutic option the of patients with acute pulmonary embolism at high risk early mortality. Current transcatheter techniques allow for local fibrinolysis or embolectomy minimal complications. Therefore, these procedures can be considered high-risk as an alternative surgical when systemic thrombolysis is contraindicated ineffective. They are also intermediate-high-risk who...

10.33963/kp.a2023.0075 article EN cc-by-nc-nd Kardiologia Polska 2023-01-01

The association between fibromuscular dysplasia (FMD) and spontaneous cervical artery dissection (SCeAD) has been recognized, but the available evidence on this relationship is scant. Therefore, main goal of our study was to systematically evaluate FMD frequency, clinical characteristics vascular bed involvement in patients with SCeAD. Among 230 referred ARCADIA-POL study, 43 (mean age 44.1 ± 8.9 years; 15 men 28 women) SCeAD were referred. Also, 135 compared without Patients underwent:...

10.1177/1358863x18811596 article EN Vascular Medicine 2019-02-10

Abstract In view of the increasing prevalence aortic stenosis (AS) in ageing populations, identifying predictors favorable clinical response to transcatheter valve implantation (TAVI) is particular importance. Typically, more severe LV function impairment believed indicate less potential for improvement after eliminating cause disease. However AS, reversibility myocardial damage and its correlation with regression symptoms replacement are explored. It suggested that work (MW) indices...

10.1093/ehjci/jeae333.124 article EN European Heart Journal - Cardiovascular Imaging 2025-01-01

The Impella percutaneous mechanical circulatory support device provides improved in treating patients with high-risk coronary interventions (HR-PCI) or cardiogenic shock. IMPELLA-PL is a multicenter registry developed to share clinical data and experiences using technology Poland. retrospective analysis conducted this study aims fill the knowledge gap of performance multivessel artery disease (CAD) depressed left ventricular ejection fraction (EF) (≤30%) treated HR-PCI. Retrospective were...

10.5603/cj.103336 article EN PubMed 2025-04-14

Abstract Aims We aimed to investigate the role of aortic valve tissue composition from quantitative cardiac computed tomography angiography (CTA) in patients with severe stenosis (AS) for differentiation disease subtypes and prognostication after transcatheter implantation (TAVI). Methods results Our study included 447 consecutive AS six high-volume centres reporting a prospective nationwide registry TAVI procedures (POL-TAVI), who underwent CTA before TAVI, 224 matched controls normal...

10.1093/ehjci/jeaa304 article EN European Heart Journal - Cardiovascular Imaging 2020-10-23

Abstract Background Extremely large aortic valve anatomy is one of the remaining limitations leading to exclusion patients for transcatheter replacement (TAVR). Aims The newly approved Myval 32 mm device designed use in annulus areas up 840 2 . Here we want share initial worldwide experience with device. Methods and Results Retrospective data were collected from 10 stenosis very annular (mean area 765.5 ), who underwent implantation heart at eight centers. Valve Academic Research...

10.1002/ccd.30820 article EN cc-by-nc-nd Catheterization and Cardiovascular Interventions 2023-09-12

Abstract One of the major pathomechanisms COVID-19 is interplay hyperinflammation and disruptions in coagulation processes, involving thrombocytes. Antiplatelet therapy (AP) by anti-inflammatory effect inhibition platelet aggregation may affect these pathways. The aim this study was to investigate if AP has an impact on in-hospital course medium-term outcomes hospitalized patients. population (2170 patients: mean ± SD age 60 19 years old, 50% male) divided into a group 274 patients receiving...

10.1038/s41598-024-55407-9 article EN cc-by Scientific Reports 2024-02-28

Background: A reduction in carotid artery blood flow (CABF) and ultimately wall shear stress (WSS) is a major driver of heightened peripheral chemoreceptor (PCh) activity animal models heart failure. However, it yet to be translated humans. To provide more insight into this matter, we considered severe aortic stenosis (AS) before after transcatheter valve implantation (TAVI) as human model body function under dramatically different hemodynamic conditions. Materials Methods: total 26 AS...

10.3390/biomedicines13030611 article EN cc-by Biomedicines 2025-03-03

ABSTRACT Background THV is a standard treatment for elderly patients with severe AS, using either BE or self‐expanding (SE) THVs. While the Myval has demonstrated safety and efficacy, data on its latest iteration, Octacor, are limited. Aims To evaluate clinical performance of next‐generation Octacor balloon‐expandable (BE) transcatheter heart valve (THV) in severe, symptomatic native aortic stenosis (AS). Methods This observational, real‐world, multicenter study involved deemed suitable TAVR...

10.1002/ccd.31563 article EN Catheterization and Cardiovascular Interventions 2025-05-05

The angioplasty procedure is associated with a release of numerous factors triggering the local inflammatory reaction in vascular wall and leading thus to restenosis. In this study, we hypothesize that low-energy laser irradiation may exert beneficial effect by limiting process. A group 101 subjects (75 men 26 women, mean age: 59.1 ± 10.3) treated percutaneous coronary intervention (PCI), were recruited study. While 52 patients (40 12 women) subjected intravascular (λ = 808 nm) dilated...

10.1007/s10103-012-1142-z article EN cc-by Lasers in Medical Science 2012-06-26
Coming Soon ...